Clinical-stage developer PleoPharma publishes new survey data characterizing cannabis withdrawal symptoms and cessation patterns among women.
PleoPharma presents survey data on cannabis withdrawal in women, but no financial or guidance impact is disclosed.
PleoPharma, Inc. released findings from a clinical-stage research survey detailing the experiences of women regarding frequent cannabis use and cessation. The study highlights specific withdrawal symptoms and challenges faced by female users during attempts to quit.
The research focuses on characterizing the experiences of women regarding frequent cannabis use, the challenges of cessation, and the specific symptoms associated with withdrawal.